AIOCD Demands GST Cut on Medicines: Life-Saving Drugs Should Be Tax-Free!

August 24, 2025

AIOCD Demands GST Cut on Medicines: Life-Saving Drugs Should Be Tax-Free!

Big news for medicine buyers! AIOCD wants all medicines taxed just 5%, and vital life-saving drugs fully free of GST. This move aims to give a big relief to patients and families across India, especially those without insurance. Will the government listen?

Tamil Nadu Launches Instant Crop Loans of Rs 17,000 Crore to Boost Farmers and Livestock

August 24, 2025

Tamil Nadu Launches Instant Crop Loans of Rs 17,000 Crore to Boost Farmers and Livestock

Tamil Nadu government rolls out an exciting instant crop loan scheme with Rs 17,000 crore support. Farmers can now get loans up to Rs 5 lakh on the very day they apply online. Plus, Rs 3,000 crore is set aside for livestock development too. This easy online process is changing the game for rural India!

New York to Send $400 Inflation Refund Checks to 8 Million Residents Starting October

August 24, 2025

New York to Send $400 Inflation Refund Checks to 8 Million Residents Starting October

Get ready, New Yorkers! Governor Kathy Hochul gives a thumbs-up to $400 inflation refund checks for millions. No applications needed. Payments start October!

RBI Taps Indranil Bhattacharyya for Top Monetary Policy Role Ahead of Big October Meet

August 24, 2025

RBI Taps Indranil Bhattacharyya for Top Monetary Policy Role Ahead of Big October Meet

RBI’s new MPC member Indranil Bhattacharyya steps in with rich experience as global trade worries and US tariffs threaten India's economy. Will his expertise tame rates and calm markets?

SEBI Panel Proposes Rs 1500 Crore Cap on Intraday Equity Index Derivatives to Tame Market Tricks

August 23, 2025

SEBI Panel Proposes Rs 1500 Crore Cap on Intraday Equity Index Derivatives to Tame Market Tricks

India's market watchdog panel suggests capping intraday equity index derivatives net positions at Rs 1,500 crore to stop manipulative trading and shield retail investors. This move aims to clear confusion and tighten monitoring rules after controversy with U.S. trading firm Jane Street rocked the market.